这种LRRK2 p.L1795F变种在欧洲人口中引起帕金森病
Lara M Lange1,2, Kristin Levine3,4, Susan H Fox5
1Institute of Neurogenetics, University of Luebeck, Luebeck, Germany.
Research square
|October 7, 2024
概括
一种新发现的LRRK2 p.L1795F变体是欧洲血统个体中自体主导帕金森病 (PD) 的致病原因. 这一发现对于基因测试和针对帕金森病的有针对性的临床试验至关重要.
科学领域:
- 遗传学 遗传学 是一个
- 神经科学是一个神经科学.
- 分子生物学分子生物学
背景情况:
- 氨酸丰富的重复激酶2 (LRRK2) 基因中的致病变体是自体主导帕金森病 (PD) 的主要原因.
- 在PD的遗传异质性需要识别新的致病变体,以了解疾病机制和改善诊断.
研究的目的:
- 识别和描述与帕金森病相关联的LRRK2基因中的新型致病变体.
- 调查LRRK2 p.L1795F变异在欧洲人口中PD病因学中的作用.
主要方法:
- 在多个大规模的PD研究计划 (GP2,AMP-PD,PDGENEration,CENTOGENE) 中对超过5万个人的基因型和测序.
- 临床评估变异载体和分析共享的单元类型,以确定遗传联系.
- 对LRRK2激酶活性发表的功能数据的审查.
主要成果:
- 该LRRK2 p.L1795F变体在14名白人/欧洲血统的PD患者中被发现,包括家族病例.
- 变异携带者共享一个共同的单元型,表明一个共同的祖先起源.
- p.L1795F载体的临床表型与其他LRRK2-相关的PD相一致.
结论:
- 这种LRRK2 p.L1795F变种具有绝对的致病性,导致欧洲人自身主导的PD.
- 这种罕见的变异应纳入PD遗传测试小组.
- 这些发现支持将LRRK2 p.L1795F纳入帕金森病的基因特异性临床试验.
相关概念视频
Parkinson's Disease: Overview
499
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
499
Neural Regulation
39.2K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.2K
Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
Parkinson's Disease: Treatment
239
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
239
Lethal Alleles
15.4K
Agouti: A Lethal Allele
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
15.4K
Single Nucleotide Polymorphisms-SNPs
14.9K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
14.9K


